Wells Fargo Maintains Overweight on BrightSpring Health, Raises Price Target to $82
Benzinga Newsdesk 7 hours ago
Analyst RatingsNewsPrice Target
Wells Fargo analyst Stephen Baxter maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and raises the price target from $78 to $82.
Wells Fargo analyst Stephen Baxter maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and raises the price target from $78 to $82.